Phone app may ease anxiety in teens and young adults after cancer
NCT ID NCT06682039
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a smartphone app designed to help young cancer survivors (ages 15-29) manage anxiety. The app uses attention bias modification (ABM) to retrain how the brain reacts to stressful triggers, along with gratitude exercises. The goal was to see if survivors would use the app and find it helpful. The study enrolled 70 participants and measured how many signed up, completed the program, and reported satisfaction.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Attention Bias Modification (ABM) smartphone app plus gratitude and savoring activities
What this could lead to
If this approach works, it could offer a simple, self-guided way to ease anxiety in young cancer survivors, improving their quality of life.
What could go wrong
This was a small, early feasibility study (70 participants) with no control group for effectiveness. It only measured whether people would use the app, not whether it actually reduces anxiety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHILDHOOD MALIGNANT SOLID NEOPLASM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fred Hutch/University of Washington/Seattle Children's Cancer Consortium
Seattle, Washington, 98109, United States